PAR 4.35% 22.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-3527

  1. 4,273 Posts.
    lightbulb Created with Sketch. 6768
    As I said, not an ideal situation, one we would have love to have avoided sure.

    But technically you are wrong. Paul has stepped into a MD role while they try and find a replacement CEO.

    Yes of course we would like these roles to be separated but I would rather wait for the right candidate, why rush this? Specially when we are at such a critical and important point. We don't want to jam any ol' Joe into a CEO role to save face.

    No no no no - we want the steady direction of the ship to be maintained...we will get these roles filled eventually with the right person in charge, let them take a bit longer to get the perfect candidate.

    My thoughts



 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
22.0¢
Change
-0.010(4.35%)
Mkt cap ! $76.95M
Open High Low Value Volume
23.5¢ 23.5¢ 21.5¢ $258.8K 1.172M

Buyers (Bids)

No. Vol. Price($)
1 10139 22.0¢
 

Sellers (Offers)

Price($) Vol. No.
23.0¢ 6077 1
View Market Depth
Last trade - 16.10pm 13/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.